Status:
UNKNOWN
The Cognitive-Behavioral Dysfunctions and the Potential of Neuroplasticity in Brain Tumors Patients During Radiotherapy
Lead Sponsor:
The Greater Poland Cancer Centre
Collaborating Sponsors:
National Science Centre, Poland
Conditions:
Brain Tumors
Radiotherapy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Primary and secondary brain tumors are a constant challenge for the medicine. Tissue sensitivity to ionizing radiation differs and depends on numerous factors and the same dose of radiation may produc...
Detailed Description
Every year, thousands of patients worldwide undergo radiotherapy (RT) for primary brain tumors (BT) and brain metastases originating from extracranial tumors. Radiation injury is multifactorial and is...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with three different CNS groups of tumors: from III and IV brain tumor groups, and metastatic tumors enrolled to RT,
- Age between 18-70 years,
- good general health conditions (according to Eastern Cooperative Oncology Group (ECOG) 0-2),
- obtaining informed consent for participation in the study.
- Exclusion criteria:
- Patients with numerous tumors (above two),
- psychological or psychiatric illnesses treated pharmacologically,
- neurological disorders (e.g. MS, Parkinson's disease, meningitis, etc.),
- significant clinical circulatory failure (above III NYHA).
Exclusion
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05192447
Start Date
April 1 2021
End Date
March 31 2025
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Greater Poland Cancer Centre
Poznan, Greater Poland Voivodeship, Poland, 61-866